Maha Hussain

2.2k total citations
23 papers, 1.2k citations indexed

About

Maha Hussain is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Maha Hussain has authored 23 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 13 papers in Oncology and 4 papers in Surgery. Recurrent topics in Maha Hussain's work include Prostate Cancer Treatment and Research (7 papers), Bladder and Urothelial Cancer Treatments (4 papers) and Prostate Cancer Diagnosis and Treatment (4 papers). Maha Hussain is often cited by papers focused on Prostate Cancer Treatment and Research (7 papers), Bladder and Urothelial Cancer Treatments (4 papers) and Prostate Cancer Diagnosis and Treatment (4 papers). Maha Hussain collaborates with scholars based in United States, Thailand and Ireland. Maha Hussain's co-authors include Laurel Northouse, Darlene Mood, Isaac J. Powell, David C. Smith, Kendra Schwartz, Jeffrey D. Forman, Kenneth J. Pienta, Trace Kershaw, Ann Schafenacker and Ulka N. Vaishampayan and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

Maha Hussain

23 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maha Hussain United States 16 569 264 259 207 163 23 1.2k
Isaac J. Ergas United States 20 788 1.4× 158 0.6× 147 0.6× 184 0.9× 93 0.6× 52 1.4k
Douglas Reding United States 13 419 0.7× 144 0.5× 105 0.4× 268 1.3× 122 0.7× 18 1.0k
M. S. Vidyasagar India 21 590 1.0× 497 1.9× 80 0.3× 201 1.0× 214 1.3× 61 1.6k
Shahpar Haghighat Iran 21 1.1k 2.0× 131 0.5× 111 0.4× 164 0.8× 126 0.8× 104 1.7k
M B McIllmurray United Kingdom 15 576 1.0× 259 1.0× 239 0.9× 452 2.2× 69 0.4× 32 1.2k
Stefan N. Symeonides United Kingdom 19 898 1.6× 319 1.2× 275 1.1× 292 1.4× 218 1.3× 58 1.4k
Yakir Rottenberg Israel 19 427 0.8× 148 0.6× 86 0.3× 135 0.7× 111 0.7× 82 1.0k
Ying Zheng China 28 1.3k 2.2× 404 1.5× 126 0.5× 205 1.0× 383 2.3× 62 2.1k
Deborah A. Boggs United States 28 560 1.0× 251 1.0× 51 0.2× 545 2.6× 206 1.3× 43 1.9k
Janise M. Roh United States 19 720 1.3× 145 0.5× 50 0.2× 146 0.7× 168 1.0× 80 1.2k

Countries citing papers authored by Maha Hussain

Since Specialization
Citations

This map shows the geographic impact of Maha Hussain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maha Hussain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maha Hussain more than expected).

Fields of papers citing papers by Maha Hussain

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maha Hussain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maha Hussain. The network helps show where Maha Hussain may publish in the future.

Co-authorship network of co-authors of Maha Hussain

This figure shows the co-authorship network connecting the top 25 collaborators of Maha Hussain. A scholar is included among the top collaborators of Maha Hussain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maha Hussain. Maha Hussain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Yutai, et al.. (2025). Response to pembrolizumab in advanced prostate cancer with predictive biomarkers. The Oncologist. 30(3). 1 indexed citations
2.
Tamura, Shuzo, Yin Wang, Brendan Veeneman, et al.. (2018). Molecular Correlates of In Vitro Responses to Dacomitinib and Afatinib in Bladder Cancer. Bladder Cancer. 4(1). 77–90. 17 indexed citations
3.
Hiles, Guadalupe Lorenzatti, Amanda D. Bucheit, John R. Rubin, et al.. (2016). ADAM15 Is Functionally Associated with the Metastatic Progression of Human Bladder Cancer. PLoS ONE. 11(3). e0150138–e0150138. 26 indexed citations
5.
Vaishampayan, Ulka N., Maha Hussain, Mousumi Banerjee, et al.. (2007). Lycopene and Soy Isoflavones in the Treatment of Prostate Cancer. Nutrition and Cancer. 59(1). 1–7. 102 indexed citations
6.
Northouse, Laurel, Darlene Mood, James E. Montie, et al.. (2007). Living With Prostate Cancer: Patients' and Spouses' Psychosocial Status and Quality of Life. Journal of Clinical Oncology. 25(27). 4171–4177. 180 indexed citations
7.
Montgomery, Bruce, Bryan Goldman, Catherine M. Tangen, et al.. (2007). Association of Body Mass Index With Response and Survival in Men With Metastatic Prostate Cancer: Southwest Oncology Group Trials 8894 and 9916. The Journal of Urology. 178(5). 1946–1951. 24 indexed citations
8.
Al‐Sukhun, Sana & Maha Hussain. (2003). Molecular biology of transitional cell carcinoma. Critical Reviews in Oncology/Hematology. 47(2). 181–193. 38 indexed citations
9.
Barnholtz‐Sloan, Jill S., Richard K. Severson, Ulka N. Vaishampayan, & Maha Hussain. (2003). Survival analysis of distant prostate cancer by decade (1973–1997) in the Detroit Metropolitan Surveillance, Epidemiology and End Results (SEER) Program Registry: has outcome improved? (United States). Cancer Causes & Control. 14(7). 681–685. 9 indexed citations
10.
Hussain, Maha, Mousumi Banerjee, Fazlul H. Sarkar, et al.. (2003). Soy Isoflavones in the Treatment of Prostate Cancer. Nutrition and Cancer. 47(2). 111–117. 113 indexed citations
11.
Harden, Janet, Ann Schafenacker, Laurel Northouse, et al.. (2002). Couples' Experiences With Prostate Cancer: Focus Group Research. Oncology nursing forum. 29(4). 701–709. 132 indexed citations
12.
Hussain, Maha, Ulka N. Vaishampayan, & David C. Smith. (2002). Novel gemcitabine-containing triplets in the management of urothelial cancer. Seminars in Oncology. 29(1). 20–24. 10 indexed citations
13.
Morrissey, Colm, Johnathon N. Lakins, Amy Moquin, Maha Hussain, & Martin Tenniswood. (2001). An antigen capture assay for the measurement of serum clusterin concentrations. Journal of Biochemical and Biophysical Methods. 48(1). 13–21. 27 indexed citations
14.
Vaishampayan, Ulka N. & Maha Hussain. (2000). Adjuvant Chemo-/Hormonal Therapy Trials for Locally Advanced Prostate Cancer. Current Oncology Reports. 2(5). 402–408. 4 indexed citations
15.
Polin, Lisa, Frederick A. Valeriote, Kathryn White, et al.. (1997). Treatment of human prostate tumors PC-3 and TSU-PR1 with standard and investigational agents in SCID mice. Investigational New Drugs. 15(2). 99–108. 41 indexed citations
16.
Hussain, Maha, Mark KuKuruga, Sandra Biggar, et al.. (1996). Prostate cancer: Flow cytometric methods for detection of bone marrow micrometastases. Cytometry. 26(1). 40–46. 17 indexed citations
18.
Hussain, Maha, et al.. (1993). Neurotoxicity of antineoplastic agents. Critical Reviews in Oncology/Hematology. 14(1). 61–75. 37 indexed citations
19.
20.
Dubaybo, Basim A., Imran Afridi, & Maha Hussain. (1991). Central Neurogenic Hyperventilation in Invasive Laryngeal Carcinoma*. CHEST Journal. 99(3). 767–769. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026